Cargando…

Potential Agents against Plasma Leakage

Shock due to severe plasma leakage may happen in infectious diseases such as severe dengue and sepsis due to various bacterial infections, which may be deleterious and may lead to death. Various substances and proteins are known to modulate the effects of proleakage mediators and counteract the dele...

Descripción completa

Detalles Bibliográficos
Autor principal: Pawitan, Jeanne Adiwinata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195382/
https://www.ncbi.nlm.nih.gov/pubmed/22084722
http://dx.doi.org/10.5402/2011/975048
_version_ 1782214122669080576
author Pawitan, Jeanne Adiwinata
author_facet Pawitan, Jeanne Adiwinata
author_sort Pawitan, Jeanne Adiwinata
collection PubMed
description Shock due to severe plasma leakage may happen in infectious diseases such as severe dengue and sepsis due to various bacterial infections, which may be deleterious and may lead to death. Various substances and proteins are known to modulate the effects of proleakage mediators and counteract the deleterious effect of plasma leakage. Some of the various substances and proteins such as focal adhesion kinase (FAK), the Rho GTPases, protein kinase A, and caveolin-1 have dual actions; therefore they are not suitable for therapy. However, sphingosine 1phosphate and its receptor agonists, Angiopoetin-1, Slit, and Bbeta15–42 may be promising.
format Online
Article
Text
id pubmed-3195382
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher International Scholarly Research Network
record_format MEDLINE/PubMed
spelling pubmed-31953822011-11-14 Potential Agents against Plasma Leakage Pawitan, Jeanne Adiwinata ISRN Pharmacol Review Article Shock due to severe plasma leakage may happen in infectious diseases such as severe dengue and sepsis due to various bacterial infections, which may be deleterious and may lead to death. Various substances and proteins are known to modulate the effects of proleakage mediators and counteract the deleterious effect of plasma leakage. Some of the various substances and proteins such as focal adhesion kinase (FAK), the Rho GTPases, protein kinase A, and caveolin-1 have dual actions; therefore they are not suitable for therapy. However, sphingosine 1phosphate and its receptor agonists, Angiopoetin-1, Slit, and Bbeta15–42 may be promising. International Scholarly Research Network 2011 2011-04-03 /pmc/articles/PMC3195382/ /pubmed/22084722 http://dx.doi.org/10.5402/2011/975048 Text en Copyright © 2011 Jeanne Adiwinata Pawitan. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Pawitan, Jeanne Adiwinata
Potential Agents against Plasma Leakage
title Potential Agents against Plasma Leakage
title_full Potential Agents against Plasma Leakage
title_fullStr Potential Agents against Plasma Leakage
title_full_unstemmed Potential Agents against Plasma Leakage
title_short Potential Agents against Plasma Leakage
title_sort potential agents against plasma leakage
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195382/
https://www.ncbi.nlm.nih.gov/pubmed/22084722
http://dx.doi.org/10.5402/2011/975048
work_keys_str_mv AT pawitanjeanneadiwinata potentialagentsagainstplasmaleakage